Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy

Cisplatin (CDDP) is commonly used to treat a multitude of tumors including sarcomas, ovarian and cervical cancers. Despite recent investigations allowed to improve chemotherapy effectiveness, the molecular mechanisms underlying the development of CDDP resistance remain a major goal in cancer researc...

Descripción completa

Detalles Bibliográficos
Autores principales: Vianello, Caterina, Cocetta, Veronica, Catanzaro, Daniela, Dorn, Gerald W, De Milito, Angelo, Rizzolio, Flavio, Canzonieri, Vincenzo, Cecchin, Erika, Roncato, Rossana, Toffoli, Giuseppe, Quagliariello, Vincenzo, Di Mauro, Annabella, Losito, Simona, Maurea, Nicola, Scaffa, Cono, Sales, Gabriele, Scorrano, Luca, Giacomello, Marta, Montopoli, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033831/
https://www.ncbi.nlm.nih.gov/pubmed/35459212
http://dx.doi.org/10.1038/s41419-022-04741-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033831/
https://www.ncbi.nlm.nih.gov/pubmed/35459212
http://dx.doi.org/10.1038/s41419-022-04741-9

Ejemplares similares